证券代码：300981 证券简称：中红医疗 公告编号：2025-088 中红普林医疗用品股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、担保情况概述 中红普林医疗用品股份有限公司（以下简称"公司"）分别于 2024 年 12 月 9 日、2024 年 12 月 25 日召开第四届董事会第四次会议、2024 年第三次临时 股东大会，审议通过了《关于公司及子公司 2025 年度向银行申请综合授信额度 暨公司为子公司申请综合授信额度提供担保的议案》，同意公司为控股子公司 2025 年度向金融机构申请的授信额度提供担保，其中，为资产负债率 70%（含） 以上的控股子公司提供担保额度为不超过 15 亿元，为资产负债率低于 70%的控 股子公司提供担保额度为不超过 10 亿元，担保额度总计不超过 25 亿元。具体内 容详见《关于公司及子公司 2025 年度向银行申请综合授信额度暨公司为子公司 申请综合授信额度提供担保的公告》（公告编号：2024-083）。 二、担保进展情况 近日，公司全资子公司江西中红普林医疗制品有限公司 ...

Core Viewpoint - The company, Zhonghong Medical, is experiencing growth in its overseas revenue, benefiting from the depreciation of the RMB and focusing on innovative medical products for diverse market needs [4][3]. Group 1: Company Overview - Zhonghong Medical specializes in the research, production, and sales of high-quality medical and industrial disposable protective gloves, with a revenue composition of 89.48% from health protection products, 6.22% from safety infusion products, and 4.30% from innovative incubation products [9]. - The company was established on December 22, 2010, and went public on April 27, 2021, with its headquarters located in Tangshan, Hebei Province [9]. Group 2: Financial Performance - For the first half of 2025, Zhonghong Medical achieved a revenue of 1.238 billion yuan, representing a year-on-year growth of 7.76%, while the net profit attributable to shareholders decreased by 82.35% to 5.7429 million yuan [10]. - The company has distributed a total of 1.251 billion yuan in dividends since its A-share listing, with 501 million yuan distributed over the past three years [11]. Group 3: Market Position and Trends - The company operates primarily through ODM direct sales, producing medical devices and consumables for overseas brand owners, which allows it to maintain a strong export focus [2]. - As of June 30, 2025, the company had a total market capitalization of 5.785 billion yuan, with a trading volume of 36.8624 million yuan on September 24, 2025 [1]. Group 4: Product Innovation and Development - Zhonghong Medical is committed to innovation, continuously launching high-performance medical products to meet diverse market demands, and integrating digital technology into product development for smart upgrades [3]. - The company showcased its veterinary infusion pumps at the 12th Beijing Pet Expo, highlighting their safety and multifunctionality, which received positive feedback from veterinary professionals [2].

Core Viewpoint - Zhonghong Medical announced that its subsidiary, Jiangxi Kelong Medical Device Manufacturing Co., Ltd., has obtained a medical device registration certificate from the National Medical Products Administration, extending the validity of the existing product registration until February 28, 2031 [1] Group 1 - The registration certificate is a continuation of the existing product registration [1] - The previous expiration date of the registration was February 28, 2026 [1] - The new effective period extends the registration by five years [1]

证券代码：300981 证券简称：中红医疗 公告编号：2025-087 中红普林医疗用品股份有限公司 关于子公司江西科伦医疗器械制造有限公司完成医疗器械 延续注册的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 中红普林医疗用品股份有限公司（以下简称"公司"）子公司江西科伦医疗 器械制造有限公司于近期取得国家药品监督管理局颁发的《中华人民共和国医疗 器械注册证》，上述注册证为原有产品的延续注册，有效期限由原 2026 年 2 月 28 日到期延续至 2031 年 2 月 28 日到期。上述注册证具体情况如下： 一、基本信息 特此公告 中红普林医疗用品股份有限公司 二、对公司的影响及风险提示 上述医疗器械注册证有效期的延长，延续了公司及子公司在一次性使用输液 用肝素帽领域的产品品类，能够保证原有产品的持续销售，并将进一步增强公司 及子公司的综合竞争力，不断满足多元化的市场需求，有利于进一步提高市场拓 展能力。 上述产品实际销售情况取决于未来市场的推广效果，产品销售及利润贡献具 有不确定性，目前尚无法预测上述产品对公司未来业绩的影响，敬请投资者注意 防范投资 ...

Core Viewpoint - The company, Zhonghong Medical, is primarily engaged in the export of medical devices and consumables, utilizing an ODM direct sales model, which allows it to design and produce products for overseas brand owners [2][4]. Group 1: Company Overview - Zhonghong Medical is a state-owned enterprise controlled by the Xiamen Municipal Government State-owned Assets Supervision and Administration Commission [5]. - The company was established on December 22, 2010, and went public on April 27, 2021. Its main business includes the research, production, and sales of high-quality nitrile gloves, PVC gloves, and other disposable protective gloves [9]. - As of June 30, 2025, the company had 20,200 shareholders, with an average of 19,502 circulating shares per person, reflecting a 0.40% increase in shareholder numbers [10]. Group 2: Financial Performance - For the first half of 2025, Zhonghong Medical achieved a revenue of 1.238 billion yuan, representing a year-on-year growth of 7.76%. However, the net profit attributable to shareholders decreased by 82.35% to 5.7429 million yuan [10]. - The company's overseas revenue accounted for 81.56% of total revenue, benefiting from the depreciation of the RMB [4]. Group 3: Product and Market Development - At the 12th Beijing Pet Expo, Zhonghong Medical showcased its innovative veterinary infusion pumps, which received positive feedback for their safety and multifunctionality [2]. - The company emphasizes innovation and digital technology integration in product development, aiming to become a leading provider of intelligent medical solutions [3]. Group 4: Market Activity - On September 23, Zhonghong Medical's stock fell by 1.76%, with a trading volume of 80.3791 million yuan and a turnover rate of 1.54%, resulting in a total market capitalization of 5.73 billion yuan [1]. - The average trading cost of the stock is 14.67 yuan, with the current price approaching a resistance level of 13.54 yuan, indicating potential for upward movement if this level is surpassed [8].

Core Viewpoint - The Shanghai Stock Exchange will review the initial public offering (IPO) of Moore Threads on September 26, aiming to raise 8 billion yuan [1] Group 1: Company Overview - Moore Threads plans to list on the Sci-Tech Innovation Board and seeks to raise 8 billion yuan through its IPO [1] - The company has direct and indirect stakes in various sectors, including electronics, computers, and communications [1] - Directly invested companies include Heertai (002402) and Yingqu Technology (002925), while indirectly invested companies include Honglida, Chuling Information (300250), and Changfei Fiber (601869) [1] Group 2: Market Performance - As of September 19, the average annual increase for the directly or indirectly invested companies is nearly 35%, with Changfei Fiber and Heertai exceeding 100% [1] - Financing data shows that as of September 18, these companies have seen an overall increase of nearly 30% in financing from investors this year [1] - Six companies, including Changfei Fiber, Heertai, and Ruifeng New Materials (300910), have received over 30% increase in financing from investors [1] Group 3: Investment Backers - In addition to A-share companies, notable investors in Moore Threads include Tencent, Lenovo, Sequoia Capital, and Houshu Capital [1]

Group 1 - The core point of the article is the announcement by Zhonghong Medical (300981) regarding the election of Mr. Jia Bin as the employee representative director of the company's fourth board of directors [1]

Group 1 - The company, Zhonghong Medical (300981), announced on the evening of September 15 that it has agreed to elect non-independent director Mr. Zhan Zhihong as a member of the fourth board of directors' remuneration assessment and nomination committee [1]

Group 1 - The core point of the article is that Zhonghong Medical (SZ 300981) held a board meeting on September 15, 2025, to discuss the re-election of members for the Compensation and Assessment Committee [1] - Zhonghong Medical's revenue for the first half of 2025 was entirely derived from the medical device industry, accounting for 100% of its income [2] - As of the report, Zhonghong Medical has a market capitalization of 6 billion yuan [2]

证券代码：300981 证券简称：中红医疗 公告编号：2025-083 中红普林医疗用品股份有限公司 2025 年第三次临时股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1. 本次股东大会没有出现否决提案的情形。 2. 本次股东大会不涉及变更以往股东大会已通过决议的情形。 一、会议召开情况和出席情况 1. 会议召开时间： 现场会议召开时间：2025 年 9 月 15 日（星期一）14:30； 网络投票时间：2025 年 9 月 15 日。其中，通过深交所交易系统进行网络投 票的时间为 2025 年 9 月 15 日 9:15－9:25，9:30－11:30 和 13:00－15:00；通 过深圳证券交易所互联网系统投票的具体时间为2025年9月15日9:15－15:00。 2. 现场会议召开地点：北京经济技术开发区科创六街 87 号四楼会议室。 3. 会议召开方式：现场表决与网络投票相结合的方式。 4. 会议召集人：公司董事会。 5. 会议主持人：董事长桑树军先生。 6. 本次股东大会的召集及召开符合《中华人民共和国公司法》《中 ...